QUOTE AND NEWS
Wall Street Journal  Apr 7  Comment 
Compugen said it isn't being investigated for insider trading by the Israeli Securities Authority, although CFO's husband is under probe.
TheStreet.com  Mar 19  Comment 
NEW YORK (TheStreet) -- Compugen was given a "buy" rating with a price target of $17 by analysts at Jefferies Group. The Israel-based drug discovery company has a 52-week low of $4.56 and a 52 week high of $14.32. Shares opened at $11.45...
Benzinga  Mar 19  Comment 
Horizon Pharma (NASDAQ: HZNP) surged 20.91% to $17.75 in the pre-market session after the company announced its plans to acquire privately held Vidara Therapeutics International for around $660 million. Exact Sciences (NASDAQ: EXAS) surged...
DailyFinance  Mar 11  Comment 
TORONTO, ONTARIO -- (Marketwired) -- 03/11/14 -- Compugen Inc. is pleased to announce that as part of Microsoft Canada's comprehensive assessment of its partners' capabilities, Compugen will continue to retain the Licensing Solutions Partner (LSP)...
Benzinga  Feb 28  Comment 
Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) today announced that it has priced an underwritten public offering of 6,000,000 ordinary shares at a price to the public of $10.50 per share. Gross proceeds to Compugen are expected to be $63 million,...
Benzinga  Feb 28  Comment 
Compugen (NASDAQ: CGEN) shares fell 16.83% to $11.81 in the pre-market trading after the company announced a proposed public offering of ordinary shares. Deckers Outdoor (NASDAQ: DECK) dipped 13.19% to $73.50 after the company expected a Q1...
SeekingAlpha  Feb 26  Comment 
By ,a href='http://www.dominoanalytics.com/'>Brian Coleman: Overview. Over the past three years, using its in-silico discovery platform for predictive drug discovery (i.e. computer models and algorithms), Compugen (CGEN) has developed a hugely...
SeekingAlpha  Feb 11  Comment 
Compugen Ltd. (CGEN) Q4 2013 Earnings Conference Call February 11, 2014 10:00 AM ET Executives Martin Gerstl - Chairman of the Board Dr. Anat Cohen-Dayag - President and CEO Analysts Keay Nakae - Chardan Capital Craig...
StreetInsider.com  Feb 11  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Compugen+Ltd+%28CGEN%29+Posts+Smaller+Q4+Loss%2C+Higher+Revs/9149435.html for the full story.





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki